New eye drop T2769 takes on Hylo-Forte in dry eye showdown
NCT ID NCT06375499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new eye drop called T2769 works as well as a standard treatment (Hylo-Forte) for people with moderate to severe dry eye. 74 adults who still had dry eye symptoms despite using artificial tears took part. The main goal was to see if T2769 could reduce eye surface damage as effectively as Hylo-Forte over 36 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Axon Clinical, s.r.o.
Prague, 15000, Czechia
-
Ermellek Egeszsegcentrum
Létavértes, Hb, 4281, Hungary
-
Ganglion Medical Center
Pécs, Baranya, 7621, Hungary
-
OFTEX, s.r.o.
Prague, 11800, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Supplement shows promise for dry eye sufferers in new study
- Saffron study for dry eye pulled before it began
- Scientists hunt for eye disease clues in your tears
- New eye drop shows promise for dry eye sufferers
- New eye drops aim to soothe dry eye sufferers
- New gel aims to soothe dry eyes in glaucoma patients